| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.877 | 0.004 | 0.946 | Aldehyde oxidase inhibitor | 0.684 0.009 CID_10431050 0.946 0.003 CID_132203 | CID_132203 | |
| 0.467 | 0.042 | 0.467 | Histamine release inhibitor | 0.278 0.136 CID_10431050 0.463 0.044 CID_132203 | ||
| 0.394 | 0.005 | 0.516 | Histamine H1 receptor antagonist | 0.516 0.004 CID_10431050 0.273 0.008 CID_132203 | CID_10431050 | |
| 0.361 | 0.012 | 0.361 | 5 Hydroxytryptamine 2 antagonist | 0.09 0.08 CID_10431050 0.284 0.018 CID_132203 | ||
| 0.364 | 0.049 | 0.37 | Vasodilator, coronary | 0.206 0.177 CID_10431050 0.37 0.046 CID_132203 | CID_132203 | |
| 0.305 | 0.005 | 0.305 | 5 Hydroxytryptamine 1F antagonist | 0.113 0.026 CID_10431050 0.217 0.009 CID_132203 | ||
| 0.368 | 0.079 | 0.368 | MAP kinase kinase 6 inhibitor | 0.287 0.149 CID_10431050 0.312 0.124 CID_132203 | ||
| 0.343 | 0.055 | 0.343 | Spasmolytic | 0.326 0.061 CID_132203 | ||
| 0.319 | 0.035 | 0.349 | Cyclic AMP phosphodiesterase inhibitor | 0.349 0.026 CID_132203 | CID_132203 | |
| 0.286 | 0.008 | 0.418 | Mediator release inhibitor | 0.418 0.005 CID_10431050 0.406 0.005 CID_132203 | CID_10431050 | |
| 0.393 | 0.115 | 0.479 | Caspase 9 stimulant | 0.479 0.068 CID_132203 | CID_132203 | |
| 0.289 | 0.012 | 0.289 | 5 Hydroxytryptamine 2A antagonist | 0.199 0.02 CID_132203 | ||
| 0.257 | 0.007 | 0.32 | Dopamine D1 antagonist | 0.063 0.046 CID_10431050 0.32 0.005 CID_132203 | CID_132203 | |
| 0.269 | 0.021 | 0.269 | Acetylcholine M1 receptor antagonist | 0.143 0.081 CID_10431050 0.231 0.031 CID_132203 | ||
| 0.258 | 0.017 | 0.258 | Antiadrenergic | 0.099 0.056 CID_10431050 0.212 0.022 CID_132203 | ||
| 0.256 | 0.017 | 0.256 | Adrenaline antagonist | 0.097 0.055 CID_10431050 0.209 0.022 CID_132203 | ||
| 0.251 | 0.013 | 0.255 | Dopamine D2 antagonist | 0.255 0.013 CID_10431050 0.234 0.014 CID_132203 | CID_10431050 | |
| 0.25 | 0.014 | 0.341 | Antihistaminic | 0.341 0.008 CID_10431050 0.131 0.038 CID_132203 | CID_10431050 | |
| 0.245 | 0.019 | 0.245 | 5 Hydroxytryptamine 2B antagonist | 0.215 0.024 CID_132203 | ||
| 0.238 | 0.015 | 0.238 | Dopamine antagonist | 0.211 0.018 CID_10431050 0.222 0.017 CID_132203 | ||
| 0.242 | 0.026 | 0.242 | 5 Hydroxytryptamine antagonist | 0.163 0.044 CID_132203 | ||
| 0.228 | 0.015 | 0.285 | Histamine antagonist | 0.285 0.01 CID_10431050 0.111 0.042 CID_132203 | CID_10431050 | |
| 0.232 | 0.022 | 0.232 | Alpha adrenoreceptor antagonist | 0.198 0.028 CID_132203 | ||
| 0.352 | 0.149 | 0.352 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.296 0.218 CID_10431050 | ||
| 0.208 | 0.009 | 0.208 | Multidrug resistance-associated protein 1 inhibitor | 0.172 0.017 CID_10431050 0.2 0.01 CID_132203 | ||
| 0.249 | 0.054 | 0.249 | MAP kinase kinase 2 inhibitor | 0.194 0.085 CID_132203 | ||
| 0.204 | 0.017 | 0.204 | 5 Hydroxytryptamine 2C antagonist | 0.147 0.027 CID_132203 | ||
| 0.215 | 0.03 | 0.335 | Toll-Like receptor 9 antagonist | 0.335 0.008 CID_10431050 0.208 0.032 CID_132203 | CID_10431050 | |
| 0.288 | 0.103 | 0.288 | Vasodilator, peripheral | 0.27 0.114 CID_10431050 0.288 0.103 CID_132203 | ||
| 0.193 | 0.025 | 0.193 | Alpha 2b adrenoreceptor antagonist | 0.179 0.029 CID_132203 | ||
| 0.18 | 0.024 | 0.18 | Alpha 1 adrenoreceptor antagonist | 0.146 0.03 CID_132203 | ||
| 0.183 | 0.031 | 0.183 | Nav1.3 sodium channel blocker | 0.12 0.074 CID_132203 | ||
| 0.163 | 0.019 | 0.163 | Alpha 1b adrenoreceptor antagonist | 0.144 0.023 CID_132203 | ||
| 0.312 | 0.168 | 0.312 | MAP kinase 1 inhibitor | 0.279 0.204 CID_132203 | ||
| 0.233 | 0.09 | 0.233 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.205 0.152 CID_132203 | ||
| 0.22 | 0.081 | 0.234 | Potassium channel blocker | 0.234 0.074 CID_10431050 | CID_10431050 | |
| 0.143 | 0.005 | 0.143 | 5 Hydroxytryptamine 3 agonist | 0.077 0.029 CID_10431050 0.114 0.01 CID_132203 | ||
| 0.17 | 0.033 | 0.17 | Antibacterial (Helicobacter pylori) | 0.108 0.103 CID_10431050 0.144 0.051 CID_132203 | ||
| 0.163 | 0.027 | 0.163 | Alpha 2c adrenoreceptor antagonist | 0.152 0.031 CID_132203 | ||
| 0.154 | 0.018 | 0.154 | 5 Hydroxytryptamine 7 antagonist | 0.054 0.05 CID_10431050 0.084 0.03 CID_132203 | ||
| 0.261 | 0.134 | 0.276 | Calcium channel activator | 0.276 0.118 CID_132203 | CID_132203 | |
| 0.183 | 0.062 | 0.241 | Antipruritic | 0.241 0.027 CID_10431050 0.136 0.112 CID_132203 | CID_10431050 | |
| 0.124 | 0.005 | 0.163 | Potassium channel (Inward rectifier) blocker | 0.163 0.004 CID_10431050 0.08 0.012 CID_132203 | CID_10431050 | |
| 0.141 | 0.025 | 0.141 | Alpha 1a adrenoreceptor antagonist | 0.115 0.031 CID_132203 | ||
| 0.155 | 0.041 | 0.155 | Acetylcholine muscarinic antagonist | 0.131 0.057 CID_132203 | ||
| 0.197 | 0.085 | 0.292 | Anticonvulsant | 0.292 0.043 CID_10431050 0.15 0.129 CID_132203 | CID_10431050 | |
| 0.159 | 0.048 | 0.159 | MAP3K9 inhibitor | 0.148 0.063 CID_132203 | ||
| 0.159 | 0.049 | 0.252 | NADPH oxidase inhibitor | 0.252 0.02 CID_132203 | CID_132203 | |
| 0.128 | 0.018 | 0.128 | Alpha 1d adrenoreceptor antagonist | 0.098 0.024 CID_132203 | ||
| 0.14 | 0.03 | 0.14 | Alpha 2 adrenoreceptor antagonist | 0.13 0.033 CID_132203 | ||
| 0.146 | 0.038 | 0.146 | GABA receptor agonist | 0.145 0.039 CID_10431050 0.093 0.085 CID_132203 | ||
| 0.183 | 0.077 | 0.183 | P-glycoprotein inhibitor | 0.18 0.08 CID_10431050 0.177 0.082 CID_132203 | ||
| 0.123 | 0.017 | 0.123 | Acetylcholine M4 receptor antagonist | 0.068 0.06 CID_10431050 0.076 0.05 CID_132203 | ||
| 0.11 | 0.007 | 0.11 | Glucosylceramidase inhibitor | 0.076 0.018 CID_10431050 0.08 0.015 CID_132203 | ||
| 0.164 | 0.063 | 0.178 | Hexokinase inhibitor | 0.178 0.05 CID_132203 | CID_132203 | |
| 0.194 | 0.094 | 0.194 | HERG channel blocker | 0.151 0.13 CID_10431050 | ||
| 0.134 | 0.034 | 0.134 | Gastric antisecretory | 0.103 0.063 CID_10431050 0.098 0.069 CID_132203 | ||
| 0.147 | 0.05 | 0.147 | Anesthetic local | 0.108 0.076 CID_132203 | ||
| 0.13 | 0.034 | 0.13 | Acetylcholine release stimulant | 0.101 0.086 CID_132203 | ||
| 0.106 | 0.014 | 0.106 | 5 Hydroxytryptamine 1A agonist | 0.042 0.035 CID_10431050 0.068 0.023 CID_132203 | ||
| 0.131 | 0.041 | 0.131 | Sphingosine 1-phosphate receptor 2 agonist | 0.12 0.055 CID_132203 | ||
| 0.124 | 0.039 | 0.124 | Protein kinase C mu inhibitor | 0.102 0.055 CID_132203 | ||
| 0.116 | 0.033 | 0.116 | mTOR complex 1 inhibitor | 0.105 0.051 CID_10431050 0.103 0.057 CID_132203 | ||
| 0.18 | 0.097 | 0.18 | Platelet aggregation inhibitor | 0.152 0.126 CID_132203 | ||
| 0.11 | 0.03 | 0.11 | GABA A receptor agonist | 0.105 0.034 CID_10431050 0.076 0.071 CID_132203 | ||
| 0.109 | 0.032 | 0.118 | Alpha 2a adrenoreceptor antagonist | 0.118 0.029 CID_132203 | CID_132203 | |
| 0.105 | 0.03 | 0.105 | 5 Hydroxytryptamine 1A antagonist | 0.086 0.037 CID_132203 | ||
| 0.101 | 0.026 | 0.101 | Dopamine D4 antagonist | 0.088 0.03 CID_132203 | ||
| 0.141 | 0.068 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.131 0.113 CID_132203 | ||
| 0.13 | 0.059 | 0.13 | Adenylate cyclase inhibitor | 0.117 0.07 CID_132203 | ||
| 0.21 | 0.141 | 0.256 | Hypoxia-inducible factor 1 alpha inhibitor | 0.256 0.095 CID_132203 | CID_132203 | |
| 0.075 | 0.006 | 0.075 | Acetylcholine M4 receptor agonist | |||
| 0.14 | 0.073 | 0.14 | Ribosomal protein S6 kinase inhibitor | 0.109 0.104 CID_132203 | ||
| 0.131 | 0.064 | 0.131 | Cholinergic antagonist | 0.106 0.088 CID_132203 | ||
| 0.086 | 0.022 | 0.086 | Protein kinase C beta inhibitor | 0.079 0.031 CID_132203 | ||
| 0.093 | 0.03 | 0.093 | Phosphodiesterase 5A inhibitor | 0.066 0.055 CID_10431050 0.081 0.039 CID_132203 | ||
| 0.084 | 0.022 | 0.084 | Acetylcholine M5 receptor antagonist | 0.063 0.038 CID_132203 | ||
| 0.098 | 0.038 | 0.098 | 5 Hydroxytryptamine 1 antagonist | 0.074 0.05 CID_132203 | ||
| 0.176 | 0.117 | 0.176 | 5 Hydroxytryptamine 3E antagonist | 0.163 0.159 CID_10431050 | ||
| 0.09 | 0.033 | 0.09 | Phosphodiesterase V inhibitor | 0.064 0.058 CID_10431050 0.079 0.042 CID_132203 | ||
| 0.124 | 0.067 | 0.124 | Acetylcholine antagonist | 0.102 0.09 CID_132203 | ||
| 0.167 | 0.11 | 0.167 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.158 0.121 CID_132203 | ||
| 0.07 | 0.015 | 0.07 | Purinergic P2Y antagonist | 0.062 0.018 CID_132203 | ||
| 0.084 | 0.035 | 0.084 | Phosphodiesterase VI inhibitor | 0.077 0.046 CID_10431050 0.075 0.051 CID_132203 | ||
| 0.116 | 0.068 | 0.116 | Transcription factor STAT6 inhibitor | 0.111 0.078 CID_132203 | ||
| 0.113 | 0.067 | 0.113 | Photosensitizer | 0.099 0.09 CID_132203 | ||
| 0.06 | 0.015 | 0.065 | DNA-dependent protein kinase inhibitor | 0.065 0.013 CID_132203 | CID_132203 | |
| 0.066 | 0.022 | 0.066 | Acetylcholine M2 receptor agonist | 0.053 0.038 CID_132203 | ||
| 0.054 | 0.011 | 0.054 | DNA gyrase subunit B inhibitor | |||
| 0.167 | 0.124 | 0.167 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.209 | 0.167 | 0.209 | Antithrombotic | |||
| 0.072 | 0.032 | 0.072 | Interferon inducer | 0.061 0.052 CID_10431050 | ||
| 0.085 | 0.045 | 0.085 | Interferon agonist | |||
| 0.074 | 0.035 | 0.074 | Dopamine D3 antagonist | 0.058 0.047 CID_132203 | ||
| 0.077 | 0.039 | 0.077 | Phospholipase D inhibitor | |||
| 0.095 | 0.057 | 0.101 | Protein kinase C zeta inhibitor | 0.101 0.05 CID_132203 | CID_132203 | |
| 0.12 | 0.084 | 0.228 | Toll-Like receptor antagonist | 0.228 0.022 CID_10431050 0.118 0.087 CID_132203 | CID_10431050 | |
| 0.046 | 0.011 | 0.046 | ATM kinase inhibitor | 0.041 0.016 CID_132203 | ||
| 0.109 | 0.077 | 0.199 | Estrogen antagonist | 0.199 0.013 CID_132203 | CID_132203 | |
| 0.068 | 0.038 | 0.068 | DNA gyrase inhibitor | |||
| 0.088 | 0.057 | 0.088 | Acetylcholine agonist | |||
| 0.081 | 0.05 | 0.157 | Macrophage migration inhibitory factor inhibitor | 0.157 0.013 CID_132203 | CID_132203 | |
| 0.059 | 0.031 | 0.059 | Myc inhibitor | |||
| 0.083 | 0.055 | 0.083 | Caspase 7 inhibitor | |||
| 0.074 | 0.047 | 0.074 | Calcium channel L-type blocker | |||
| 0.036 | 0.01 | 0.037 | Potassium channel (Inward rectifier) 1 blocker | 0.037 0.009 CID_10431050 0.03 0.022 CID_132203 | CID_10431050 | |
| 0.058 | 0.033 | 0.058 | 5 Hydroxytryptamine 1 agonist | |||
| 0.066 | 0.042 | 0.066 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.172 | 0.148 | 0.172 | RNA-directed DNA polymerase inhibitor | |||
| 0.083 | 0.061 | 0.083 | mTOR complex 2 inhibitor | |||
| 0.082 | 0.059 | 0.082 | Transforming growth factor beta 3 antagonist | |||
| 0.196 | 0.175 | 0.245 | Caspase 3 stimulant | 0.245 0.116 CID_132203 | CID_132203 | |
| 0.095 | 0.074 | 0.175 | Estrogen receptor beta antagonist | 0.175 0.012 CID_132203 | CID_132203 | |
| 0.063 | 0.042 | 0.063 | Acetylcholine M2 receptor antagonist | |||
| 0.097 | 0.077 | 0.11 | DNA intercalator | 0.11 0.064 CID_132203 | CID_132203 | |
| 0.027 | 0.01 | 0.027 | Phosphodiesterase 6A inhibitor | 0.025 0.012 CID_10431050 0.023 0.016 CID_132203 | ||
| 0.095 | 0.078 | 0.112 | Beta glucuronidase inhibitor | 0.112 0.054 CID_132203 | CID_132203 | |
| 0.048 | 0.033 | 0.048 | Cytokine production stimulant | |||
| 0.064 | 0.051 | 0.064 | 5 Hydroxytryptamine agonist | |||
| 0.146 | 0.133 | 0.146 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.063 | 0.051 | 0.063 | Acetylcholine M5 receptor agonist | |||
| 0.049 | 0.038 | 0.087 | H+/K+-transporting ATPase inhibitor | 0.087 0.011 CID_10431050 | CID_10431050 | |
| 0.049 | 0.039 | 0.049 | mTOR inhibitor | |||
| 0.098 | 0.088 | 0.137 | Topoisomerase II inhibitor | 0.137 0.056 CID_132203 | CID_132203 | |
| 0.186 | 0.178 | 0.243 | Cholesterol antagonist | 0.243 0.13 CID_132203 | CID_132203 | |
| 0.102 | 0.093 | 0.102 | MAP kinase kinase inhibitor | |||
| 0.064 | 0.055 | 0.064 | Protein kinase B alpha inhibitor | |||
| 0.076 | 0.068 | 0.076 | Calcium antagonist | |||
| 0.052 | 0.045 | 0.052 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.085 | 0.079 | 0.085 | MAP kinase kinase 1 inhibitor | |||
| 0.039 | 0.033 | 0.042 | Dopamine D5 antagonist | 0.042 0.031 CID_132203 | CID_132203 | |
| 0.053 | 0.048 | 0.053 | Protein kinase C iota inhibitor | |||
| 0.039 | 0.035 | 0.047 | Dopamine D2 agonist | 0.041 0.034 CID_10431050 0.047 0.029 CID_132203 | CID_132203 | |
| 0.029 | 0.027 | 0.029 | LIM domain kinase 2 inhibitor | |||
| 0.038 | 0.04 | 0.04 | Phosphodiesterase 3B inhibitor | 0.04 0.037 CID_132203 | CID_132203 | |
| 0.053 | 0.059 | 0.066 | Dopamine agonist | 0.066 0.047 CID_132203 | CID_132203 | |
| 0.046 | 0.051 | 0.077 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.077 0.018 CID_132203 | CID_132203 | |
| 0.083 | 0.09 | 0.095 | Interleukin 12 antagonist | 0.095 0.063 CID_132203 | CID_132203 | |
| 0.087 | 0.097 | 0.112 | Chelator | 0.112 0.062 CID_132203 | CID_132203 | |
| 0.154 | 0.166 | 0.236 | DNA damaging | 0.236 0.089 CID_10431050 | CID_10431050 | |
| 0.082 | 0.095 | 0.094 | Nav1.1 sodium channel blocker | 0.094 0.074 CID_132203 | CID_132203 | |
| 0.058 | 0.072 | 0.064 | Histone deacetylase SIRT1 stimulant | 0.064 0.062 CID_132203 | CID_132203 | |
| 0.058 | 0.072 | 0.064 | Histone deacetylase stimulant | 0.064 0.062 CID_132203 | CID_132203 | |
| 0.054 | 0.069 | 0.066 | Lipase inhibitor | 0.066 0.058 CID_132203 | CID_132203 | |
| 0.067 | 0.091 | 0.083 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.083 0.059 CID_132203 | CID_132203 | |
| 0.063 | 0.089 | 0.097 | Estrogen receptor alpha antagonist | 0.097 0.029 CID_132203 | CID_132203 | |
| 0.07 | 0.102 | 0.11 | Topoisomerase I inhibitor | 0.094 0.075 CID_10431050 0.11 0.062 CID_132203 | CID_132203 | |
| 0.018 | 0.053 | 0.053 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.053 0.014 CID_132203 | CID_132203 | |
| 0.068 | 0.104 | 0.087 | Breast cancer-resistant protein inhibitor | 0.087 0.07 CID_132203 | CID_132203 | |
| 0.024 | 0.06 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.018 CID_132203 | CID_132203 | |
| 0.128 | 0.169 | 0.155 | Catenin beta inhibitor | 0.155 0.095 CID_132203 | CID_132203 | |
| 0.134 | 0.181 | 0.159 | Vasodilator | 0.159 0.144 CID_132203 | CID_132203 | |
| 0.078 | 0.126 | 0.15 | Amylase inhibitor | 0.15 0.064 CID_132203 | CID_132203 | |
| 0.087 | 0.146 | 0.12 | CDC-like kinase 1 inhibitor | 0.12 0.095 CID_132203 | CID_132203 | |
| 0.029 | 0.094 | 0.068 | Cannabinoid CB1 receptor agonist | 0.068 0.036 CID_10431050 | CID_10431050 | |
| 0.087 | 0.179 | 0.173 | Amyloid beta aggregation inhibitor | 0.173 0.093 CID_132203 | CID_132203 | |
| 0.092 | 0.193 | 0.143 | Platelet adhesion inhibitor | 0.143 0.115 CID_132203 | CID_132203 | |
| 0.012 | 0.114 | 0.073 | Estrogen agonist | 0.073 0.025 CID_132203 | CID_132203 | |
| 0.018 | 0.128 | 0.032 | Benzodiazepine receptor peripheral-type antagonist | 0.032 0.028 CID_10431050 | CID_10431050 | |
| 0.096 | 0.216 | 0.14 | Sphingosine 1-phosphate receptor 5 antagonist | 0.14 0.079 CID_10431050 | CID_10431050 | |
| 0.149 | 0.271 | 0.236 | 15-Lipoxygenase inhibitor | 0.236 0.177 CID_132203 | CID_132203 | |
| 0.056 | 0.187 | 0.114 | Alkylator | 0.114 0.074 CID_10431050 | CID_10431050 | |
| 0.004 | 0.153 | 0.03 | Estrogen receptor alpha agonist | 0.03 0.026 CID_132203 | CID_132203 | |
| 0.078 | 0.281 | 0.166 | Free radical scavenger | 0.166 0.128 CID_132203 | CID_132203 | |
| 0.052 | 0.273 | 0.276 | Interleukin 1 antagonist | 0.276 0.014 CID_10431050 | CID_10431050 | |
| 0.034 | 0.266 | 0.076 | Viral attachment inhibitor | 0.076 0.059 CID_10431050 | CID_10431050 | |
| 0.017 | 0.279 | 0.064 | Leukotriene synthesis inhibitor | 0.064 0.05 CID_10431050 | CID_10431050 | |
| 0.067 | 0.346 | 0.215 | Beta lactamase inhibitor | 0.215 0.176 CID_10431050 | CID_10431050 | |
| 0.07 | 0.365 | 0.187 | Thyroid hormone beta antagonist | 0.187 0.166 CID_10431050 | CID_10431050 | |
| 0.049 | 0.346 | 0.21 | Interleukin antagonist | 0.21 0.079 CID_10431050 | CID_10431050 | |
| 0.035 | 0.378 | 0.295 | Interleukin 1b antagonist | 0.295 0.009 CID_10431050 | CID_10431050 | |
| 0.01 | 0.386 | 0.065 | CC chemokine 5 receptor antagonist | 0.065 0.022 CID_10431050 | CID_10431050 | |
| 0.037 | 0.499 | 0.204 | Tumour necrosis factor alpha release inhibitor | 0.204 0.106 CID_10431050 | CID_10431050 | |
| 0.056 | 0.597 | 0.202 | Sodium/bile acid cotransporter inhibitor | 0.202 0.185 CID_132203 | CID_132203 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |